# LANGLARA
> **BLA761412** · Biologics License Application · Sponsor: SUNSHINE LAKE PHARMA CO LTD · Approved 2026-04-29
## Drug
- **FDA Application Number:** BLA761412
- **Application type:** Biologics License Application
- **Brand name:** LANGLARA
- **Generic name:** Insulin Glargine-Aldy
- **Active ingredients:** INSULIN GLARGINE-ALDY
- **Dosage form:** INJECTABLE
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** SUNSHINE LAKE PHARMA CO LTD
- **First approval:** 2026-04-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761412)
---
*AI Analytics · CC0 1.0*